|
Kim D. Blickenstaff — Chairman
Former President and Chief Executive Officer
Biosite Incorporated
Daniel D. Adams
President and Chief Executive Officer
Protein Sciences Corporation
Gregory H. Bailey, M.D.
Managing Partner
Palantir Group, Inc.
David T. Hung, M.D.
President and Chief Executive Officer
Medivation, Inc.
W. Anthony Vernon
Former Company Group Chairman
DePuy Orthopedics, Inc.
Former President
Centocor, Inc.
Kim D. Blickenstaff — Chairman
Former President and Chief Executive Officer
Biosite Incorporated
Mr. Blickenstaff served as the president and chief executive officer of Biosite Incorporated, a public medical diagnostics company, from 1988 until its acquisition in 2007. He is also a director of several privately-held medical products companies. Prior to joining Biosite, he held various positions in finance, operations, research management, sales management, strategic planning and marketing with Baxter Travenol, National Health Laboratories and Hybritech Incorporated. Mr. Blickenstaff received a B.A. from Loyola Marymount College and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.
Top
Daniel D. Adams
President and Chief Executive Officer
Protein Sciences Corporation
Mr. Adams has been the president and chief executive officer of Protein Sciences Corporation, a biopharmaceutical service company, since 1995. He has founded a number of life sciences companies, including Biogen, where he served as the first chief executive officer. Mr. Adams holds a B.A. degree in chemistry from Cornell University and a J.D. magna cum laude from New York University School of Law.
Top
Gregory H. Bailey, M.D.
Managing Partner
Palantir Group, Inc.
Dr. Bailey has been managing partner of Palantir Group, Inc., a biotechnology merchant bank, since 2007. He was managing director of investment banking at MDB Capital Group from 2004 to 2007, and a life sciences analyst at Participating Capital from 1995 to 2004. Dr. Bailey holds an M.D. degree from the University of Western Ontario.
Top
David T. Hung, M.D.
President and Chief Executive Officer
Dr. Hung became president and chief executive officer of Medivation, Inc. and a member of the Board of Directors when the Company acquired its subsidiary Medivation Neurology, Inc. in December 2004. He served as president, chief executive officer and director of Medivation Neurology, Inc. since its inception in September 2003. From 1998 to 2001, Dr. Hung served as chief scientific officer (1998-1999) and as president, chief executive officer and director (1999-2001) of ProDuct Health, Inc., a privately-held medical device company. ProDuct Health, Inc. took its first product (a breast cancer cytological diagnostic product) from a prototype design through a 507 patient clinical trial and through FDA marketing clearance in 16 months. It was acquired in 2001 by Cytyc Corporation for $167 million after having spent only approximately $22 million in total development costs. From 1994 to1998, Dr. Hung served in various senior positions at Chiron Corporation, most recently as vice president of lead discovery and development and vice president of new projects. Dr. Hung received an M.D. Alpha Omega Alpha from the University of California, San Francisco, School of Medicine, and an A.B. summa cum laude in biology from Harvard College
Top
W. Anthony Vernon
Former Company Group Chairman
DePuy Orthopedics, Inc.
Former President
Centocor, Inc.
Mr. Vernon has nearly 25 years of experience serving in senior executive positions at various Johnson & Johnson companies, including company group chairman of DePuy Orthopedics, Inc. (2004-2005), president of Centocor, Inc. (2001-2004), president of McNeil Consumer Healthcare (1999-2001), and president worldwide of the Johnson & Johnson Merck Joint Venture. Mr. Vernon received a B.A. from Lawrence University and an M.B.A. from the Northwestern University Kellogg Graduate School of Management.
Top
|
